Developments in the Liver Health Supplements Research

The global liver health supplements market is estimated to grow at a CAGR of 4.5% during the forecast period (2024-2031). The market growth is driven by the growing incidences of liver diseases (such as Non-Alcoholic Fatty Liver Disease (NAFLD), liver cancer, and more), increasing demand for dietary supplements, and the shift towards a healthy lifestyle. New product launches are also supporting the industry's growth. The market is segmented into the product (into vitamins and minerals, herbal supplements, and others), dosage form (into capsule, tablet, powder, liquid, and others), distribution channel (into online and offline), and geographies (into North America, Europe, Asia-Pacific, and the Rest of the World). Offline is further sub-segmented into specialty stores, supermarkets hypermarkets, and others.

Browse the full report description of “Global Liver Health Supplements Market Size, Share & Trends Analysis Report, By Product (Vitamins and Minerals, Herbal Supplements, and Others), By Dosage Form (Capsule, Tablet, Powder, Liquid, and Others), By Distribution Channel (Online and Offline) and Forecast, 2024-2031” at https://www.omrglobal.com/industry-reports/liver-health-supplements-market

Market Highlights and Recent Developments

• In 2019, herbal supplements held the largest share in the market owing to their significant adoption for the treatment of liver disorders. Specialty supplements are the second most commonly consumed supplement. 

• Additionally, the North American region is anticipated to hold a considerable share of the market owing to the increasing prevalence of liver disorders in the region. As per the Centers for Disease Control and Prevention (CDC), in 2018, there were 4.5 million adults diagnosed with liver disease in the US, which is 1.8% of the total adult population.  

• According to the American Cancer Society 2023 report, 41,210 new cases of liver and intrahepatic bile duct cancer are estimated to be diagnosed in the United States in 2023.

• In May 2022 American Liver Foundation launched a nationwide screening and public awareness campaign named Think Liver Think Life. The objective of the campaign was to test children and adults at risk for fatty liver disease in all 50 states of the United States over the next five years. Such initiatives contribute significantly towards the regional market growth. 

• A research study published in the Asian Pacific Journal of Cancer Prevention stated that vitamin D deficiency is associated with an increased risk of liver cancer.

• In October 2022, Liver health-focused brand, ‘The Plug’ launched Plug Pills for liver care. The Plug Pill's formula consists of a blend of 13 herbs and antioxidant ingredients, including milk thistle, turmeric, and B vitamins.

• In June 2022, Healeo Nutrition launched the DNA-based Fatty liver reversal program in Banglore, India. The program intends to offer customers personalized nutrition programs based on their genetic reports which can reverse up to stage 2 fatty liver within 12 weeks.

The major players in the global liver health supplements market include Amway Corp., The Himalaya Drug Co., BASF SE, General Nutrition Corp., Vitaco Health Ltd., and others. The market players are contributing considerably to the market growth by the adoption of various market strategies. For instance, in November 2019, BASF Nutrition & Health declared to launch an omega 3 fatty acid solution, Hepacor in Switzerland. It is manufactured with proprietary technology which aims to support patients to manage NAFLD. With this launch in Switzerland, BASF is bringing Hepacor to the first market in continental Europe.

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/liver-health-supplements-market